Spectranetics Corporation Completes Acquisition Of AngioScore, Inc.

COLORADO SPRINGS, Colo., June 30, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that it has completed the acquisition of AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons, for $230 million in cash, along with additional contingent commercial and regulatory milestone payments.

Help employers find you! Check out all the jobs and post your resume.